ImmuneID Investors

15 investors on Angel Roster list ImmuneID in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name ImmuneID can appear together.

Investors listed
15
With verified email
67%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 ImmuneID investors

The most complete profiles first. Showing 15 of 15.

  • Brandon FarwellVerified

    Venture Capital, Micro VC · United States

    SeedPre-SeedHealth CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Service, NewtonX, Factor, Kiite and 19 more

    Verified email available

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Christoph WestphalVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Rich AldrichVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David DonabedianVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Patrick S. ChungVerified

    Venture Capital, Micro VC · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Service, NewtonX, Factor, Kiite and 19 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Lea Hachigian

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many ImmuneID investors are on Angel Roster?

Angel Roster lists 15 ImmuneID investors. 10 of them (67%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (15), Private Equity Firms (6) and Founder-Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do ImmuneID investors invest in?

Among those that list a stage, the most common are Series B (6), Seed (3) and Pre-Seed (1).

Where are ImmuneID investors based?

Most are based in the United States (14) and the United Kingdom (1).

Which companies have ImmuneID investors backed?

The most-backed portfolio companies among them are Nebula Genomics (11), EGenesis (9), Locanabio (9), Cero Therapeutics (9) and Hangzhou Just Biotherapeutics (Just China) (9).

How do I contact ImmuneID investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.